CoChat

Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety

Tamminga, Carol A., Mack, Randall J., Granneman, G. Richard, Silber, Christopher J., Kashkin, Kenneth B. · 1997 · International Clinical Psychopharmacology
Cited by 36

The DOI matches its Crossref record.

Abstract

Evidence from clinical trials supports the claim that sertindole is a potent antipsychotic drug at a dose of 12-24 mg/day. Its action against positive symptoms is as potent as that of the traditional antipsychotic haloperidol. Its action against negative symptoms is significantly different from that of placebo and quantitatively larger than that of haloperidol. Its most distinctive characteristic is a reduction in motor side effects over a whole range of comparable drug and comparator doses. More work is needed to determine whether sertindole's actions against negative symptoms influence the primary or the secondary negative system. There are insufficient data at present to compare sertindole with the highly efficacious drug clozapine or the other new antipsychotic olanzapine.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004850-199702001-00005

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 36

Metadata

Authors
Tamminga, C. A., Mack, R. J., Granneman, G. R., Silber, C. J., & Kashkin, K. B.
Venue
International Clinical Psychopharmacology
Published
1997-02
Volume
12
Pages
S29-S36
ISSN
0268-1315 (ISSN-L)
OpenAlex
W2011989818
Cited by
36
References
0
FWCI
3.54
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety. https://app.cochat.ai/papers/10.1097/00004850-199702001-00005
The paper
Tamminga, C. A., Mack, R. J., Granneman, G. R., Silber, C. J., & Kashkin, K. B. (1997). Sertindole in the treatment of psychosis in schizophrenia: efficacy and safety. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199702001-00005

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.